References
- Hart LG, Deyo RA, Cherkin DC. Physician office visits for low back pain. Frequency, clinical evaluation, and treatment patterns from a U.S. national survey. Spine 1995;20:11–9
- Blount BW, Hart G, Ehreth JL. A description of the content of army family practice. J Am Board Fam Pract 1993;6:143–52
- Feuerstein M, Marcus SC, Huang GD. National trends in non-operative care for nonspecific back pain. Spine J 2004;4:56–63
- Prevalence of disabilities and associated health conditions among adults – United States. 1999 [published correction appears in MMWR Wkly 2001;50:149]. MMWR Wkly 2001;50: 120–5
- Frymoyer JW, Cats-Baril WL. An overview of the incidences and costs of low back pain. Orthop Clin North Am 1991;22:263–71
- Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S. The health and productivity cost burden of the ‘top 10’ physical and mental health conditions affecting six large U.S. employers in 1999. J Occup Environ Med 2003;45:5–14
- Toth PP, Urtis J. Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone. Clin Ther 2004;26:1355–67
- Basmajian JV. Acute back pain and spasm. A controlled multicenter trial of combined analgesic and antispasm agents. Spine 1989;14:438–9
- Borenstein DG, Lacks S, Wiesel SW. Cyclobenzaprine and naproxen versus naproxen alone in the treatment of acute low back pain and muscle spasm. Clin Ther 1990;12:125–31
- Fossaluzza V, De Vita S. Combined therapy with cyclobenzaprine and ibuprofen in primary fibromyalgia syndrome. Int J Clin Pharmacol Res 1992;12:99–102
- Turturro MA, Frater CR, D’Amico FJ. Cyclobenzaprine with ibuprofen versus ibuprofen alone in acute myofascial strain: a randomized, double-blind clinical trial. Ann Emerg Med 2003;41:818–26
- Borenstein DG, Korn S. Efficacy of low-dose regimen of cyclobenzaprine hydrochloride in acute skeletal muscle spasm: results of two placebo-controlled trials. Clin Ther 2003;25:1056–73
- Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine 2000;25:2846–7
- Hägg O, Fritzell P, Nordwall A. The clinical importance of changes in outcome scores after treatment for chronic low back pain. Eur Spine J 2003;12:12–20
- Flexeril® (cyclobenzaprine HCl) prescribing information. Fort Washington, PA: McNeil Consumer & Specialty Pharmaceuticals; February 2003
- Katz WA, Dubé J. Cyclobenzaprine in the treatment of acute muscle spasm: review of a decade of clinical experience. Clin Ther 1988;10:216–28
- Browning R, Jackson JL, O’Malley PG. Cyclobenzaprine and back pain. A meta-analysis. Arch Intern Med 2001;161: 1613–20
- Innes GD, Croskerry P, Worthington J, Beveridge R, Jones D. Ketorolac versus acetaminophen-codeine in the emergency department treatment of acute low back pain. J Emerg Med 1998;16:549–56
- Palangio M, Morris E, Doyle RT Jr, Dornseif BE, Valente TJ. Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of moderate or severe acute low back pain. Clin Ther 2002; 24:87–99